Searched for: person:auerbr01
in-biosketch:yes
Chemotherapy in psoriasis
Auerbach R
ORIGINAL:0004620
ISSN: 0737-6081
CID: 38481
Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis
Geronemus RG; Auerbach R; Tobias H
The possibility of hepatotoxic reactions in 24 patients receiving long-term methotrexate therapy for psoriasis was evaluated by both liver biopsies and technetium TC 99 m sulfur-colloid liver scans. The two diagnostic methods were compared in a retrospective analysis. Six of 17 patients with clinically normal liver biopsy interpretations were found to have abnormal liver scans, while three of five patients with histologically proved fibrosis had completely normal liver scans. We conclude that hepatotoxic reactions from long-term methotrexate use in psoriasis cannot be reliably evaluated by the technetium Tc 99m sulfur colloid liver scan.
PMID: 7114866
ISSN: 0003-987x
CID: 9216
Methotrexate guidelines--revised
Roenigk HH Jr; Auerbach R; Maibach HI; Weinstein GD
PMID: 7037877
ISSN: 0190-9622
CID: 38365
Dyskeratosis congenita and intracranial calcifications [Letter]
Lieblich LM; Auerbach R; Auerbach AD
PMID: 7294840
ISSN: 0003-987x
CID: 38334
Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals
Robinson JK; Baughman RD; Auerbach R; Cimis RJ
Fibrosis of the liver developed to a degree that contraindicated further treatment with methotrexate in 11 of 43 patients who had been receiving maintenance therapy with methotrexate for psoriasis. Liver biopsy had been performed prior to initiation of methotrexate therapy and was repeated at 12- to 18-month intervals. In this retrospective study, age of the patient and duration of therapy have been found to be significant factors in those patients receiving only the weekly oral dosage schedule. Yearly biopsies of the liver are recommended for patients who receive methotrexate throughout their courses of therapy
PMID: 7369769
ISSN: 0003-987x
CID: 38335
Recurrent pyogenic granuloma with multiple satellites
Pearlstein HH; Auerbach R
ORIGINAL:0004617
ISSN: 0010-7069
CID: 38478
Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris [Case Report]
Auerbach R; Bystryn JC
A patient with pemphigus vulgaris and serious side effects of steroid therapy was treated by exchange plasmapheresis. Eight plasmaphereses were performed over six weeks. Each procedure reduced the serum level of intercellular antibodies by 50% to 87%. A rebound in levels of intercellular antibodies usually followed their depletion but could be minimized or completely suppressed by administration of cyclophosphamide. After six weeks of therapy, clinical symptoms had greatly improved and intercellular antibody levels had decreased from a titer of 5,120 to 160. It is not possible to ascribe these improvements specifically to plasmapheresis since the patient was concurrently receiving low doses of prednisone and intermittent treatment with cyclophosphamide
PMID: 453877
ISSN: 0003-987x
CID: 16286
Cell Development
Auerbach R
PMID: 17834715
ISSN: 1095-9203
CID: 93963
DYSKERATOSIS CONGENITA - CYTOGENETIC STUDIES IN A FAMILY WITH AN UNUSUAL PATTERN OF INHERITANCE [Meeting Abstract]
Auerbach, AD; Lieblich, LM; Ehrenbard, L; Auerbach, R; Chaganti, RSK
ISI:A1979HZ74200204
ISSN: 0002-9297
CID: 28053
Hypopigmentation at the site of application of a tourniquet [Case Report]
Testa NN; Waingankar S; Auerbach R
Hypopigmentation at a site of application of a tourniquet has not to our knowledge been reported in the literature. We are reporting such a case. We have conjectured that this hypopigmentation may be due to temporary anoxia suffered by melanocytes
PMID: 659701
ISSN: 0148-0812
CID: 38360